SARAH HAWKINS: Open Payments
NPI 1194345843 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,567 in 110 payments from 30 companies in 2025. Trend: 2023 $2,569 · 2024 $3,540 · 2025 $2,567
Food & beverage: $2,567
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $357 |
| UCB, Inc. | 13 | $295 |
| PFIZER INC. | 16 | $256 |
| ARGENX US, INC. | 7 | $209 |
| Novartis Pharmaceuticals Corporation | 8 | $199 |
| Biogen, Inc. | 8 | $196 |
| Lundbeck LLC | 4 | $119 |
| Neurocrine BioSciences, Inc. | 3 | $107 |
| Janssen Biotech, Inc. | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
Products named: KESIMPTA, NURTEC ODT, Rystiggo, UBRELVY, VYEPTI, VYVGART HYTRULO, INGREZZA, Nayzilam.
Industry payments across GA — which companies pay providers there.
